Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership216,917 shares
Latest Disclosed Value $ 3,088,819
Sei Investments Co reports 29.49% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 216,917 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $3,088,898 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 307,632 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -29.49% during the quarter. The current value of the position is $3,143,127 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 216,917 -90,715 -29.49 3,089 27.39 0.0030
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 307,632 66,343 27.50 2,424 75.40 0.0026
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 241,289 55,601 29.94 1,383 -8.78 0.0016
2025-05-14 2025-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 185,688 -33,226 -15.18 1,515 -26.53 0.0020
2025-05-13 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 224,932 6,018 2,101 0.0023
2025-02-11 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 218,914 -3,359 -1.51 2,062 -13.11 0.0026
2024-11-12 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 222,273 -19,858 -8.20 2,374 -1.21 0.0031
2024-08-13 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 242,131 19,416 8.72 2,403 -8.43 0.0034
2024-05-07 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 222,715 19,366 9.52 2,624 -9.08 0.0038
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 203,349 40,864 25.15 2,886 46.08 0.0046
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 162,485 -76,606 -32.04 1,976 -34.21 0.0036
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 239,091 -29,376 -10.94 3,003 0.84 0.0052
2023-05-12 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 268,467 -45,614 -14.52 2,977 -22.35 0.0055
2023-02-10 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 314,081 -89,368 -22.15 3,835 -8.97 0.0085
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 403,449 -59,682 -12.89 4,212 -15.29 0.0094
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 463,131 24,791 5.66 4,972 19.78 0.0107
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 438,340 -7,342 -1.65 4,151 -19.35 0.0083
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 445,682 -15,311 -3.32 5,147 16.92 0.0097
2021-11-12 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 460,993 -10,092 -2.14 4,402 -3.06 0.0092
2021-08-06 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 471,085 23,152 5.17 4,541 -12.71 0.0101
2021-05-12 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 447,933 -182,668 -28.97 5,202 -64.28 0.0131
2021-02-08 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 630,601 504 0.08 14,563 63.65 0.0376
2020-12-04 2020-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 630,097 40,617 6.89 8,899 0.11 0.0258
2020-11-06 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 630,097 40,617 8,899 21,426.8134
2020-08-17 2020-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 589,480 -11,834 -1.97 8,889 59.99 0.0276
2020-08-11 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 593,612 -7,702 5,782 15,683.9828
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 601,314 7,702 1.30 5,556 -3.91 0.0204
2020-02-06 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 593,612 256,890 76.29 5,782 114.07 0.0172
2019-11-12 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 336,722 -14,940 -4.25 2,701 -38.46 0.0069
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 351,662 20,511 6.19 4,389 -2.55 0.0143
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 331,151 50,005 17.79 4,504 32.51 0.0151
2019-02-13 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 281,146 0 0.00 3,399 0.00 0.0121
2018-11-08 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 281,146 247,004 723.46 3,399 536.52 0.0123
2018-08-03 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 34,142 33,910 14,616.38 534 17,700.00 0.0018
2018-05-11 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 232 0 0.00 3 0.00 0.0000
2018-02-08 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 232 12 5.45 3 0.00 0.0000
2017-11-06 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 220 0 0.00 3 50.00 0.0000
2017-07-31 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 220 220 2 0.0000
2016-05-10 2016-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 0 0 0 0.0000
2016-02-03 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -47,832 -100.00 0 -100.00
2015-11-02 2015-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 47,832 47,832 669 0.0061
2015-10-30 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 47,832 670
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.